AG˹ٷ

STOCK TITAN

[Form 4] Inspire Veterinary Partners, Inc. Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

Frank Richard, Chief Financial Officer of Inspire Veterinary Partners, Inc. (IVP), acquired 58,480 stock options on 04/01/2025. The options carry a $1.71 exercise price, are exercisable on 04/01/2025 and expire 04/01/2035, each covering one Class A common share. The reported ownership is direct. The Form 4 notes the filing was late due to an inadvertent administrative error and is signed 08/06/2025.

Frank Richard, direttore finanziario di Inspire Veterinary Partners, Inc. (IVP), ha acquisito 58,480 opzioni su azioni il 04/01/2025. Le opzioni hanno un prezzo di esercizio di $1.71, sono esercitabili dal 04/01/2025 e scadono il 04/01/2035, ciascuna relativa a una azione ordinaria di Classe A. La titolarità segnalata è diretta. Il Modulo 4 indica che la presentazione è avvenuta in ritardo per un errore amministrativo involontario ed è firmato il 08/06/2025.

Frank Richard, director financiero de Inspire Veterinary Partners, Inc. (IVP), adquirió 58,480 opciones sobre acciones el 04/01/2025. Las opciones tienen un precio de ejercicio de $1.71, son ejercitables el 04/01/2025 y vencen el 04/01/2035, cada una por una acción ordinaria de Clase A. La titularidad declarada es directa. El Formulario 4 señala que la presentación se hizo con retraso debido a un error administrativo involuntario y está firmado el 08/06/2025.

Frank Richard, Inspire Veterinary Partners, Inc. (IVP)� 최고재무책임�(CFO)� 04/01/2025� 58,480주의 주식매수선택권을 취득했습니다. � 옵션� 행사가격은 $1.71이며 04/01/2025� 행사 가능하� 04/01/2035� 만료되며, � 옵션은 클래� A 보통� 1주를 대상으� 합니�. 보고� 소유 형태� 직Ϊ입니�. Form 4에는 제출� 우발적인 행정 실수� 지연되었음� 기재되어 있으� 08/06/2025� 서명되었습니�.

Frank Richard, directeur financier de Inspire Veterinary Partners, Inc. (IVP), a acquis 58,480 options d'achat d'actions le 04/01/2025. Les options ont un prix d'exercice de 1,71 $, sont exerçables le 04/01/2025 et expirent le 04/01/2035, chacune portant sur une action ordinaire de catégorie A. La propriété déclarée est directe. Le formulaire 4 indique que le dépôt a été retardé en raison d'une erreur administrative involontaire et est signé le 08/06/2025.

Frank Richard, Chief Financial Officer von Inspire Veterinary Partners, Inc. (IVP), erwarb am 04/01/2025 58,480 Aktienoptionen. Die Optionen haben einen Ausübungspreis von $1.71, sind am 04/01/2025 ausübbar und laufen am 04/01/2035 ab, wobei jede Option eine Class-A-Stammaktie abdeckt. Das gemeldete Eigentum ist direkt. Im Formular 4 wird vermerkt, dass die Einreichung aufgrund eines unbeabsichtigten administrativen Fehlers verspätet erfolgte; das Formular ist am 08/06/2025 unterschrieben.

Positive
  • 58,480 stock options acquired by the CFO, each exercisable into one Class A common share
  • Exercise price disclosed: $1.71 per share with exercisable date 04/01/2025 and expiration 04/01/2035
Negative
  • Form 4 was filed late; the filer cites an inadvertent administrative error
  • The form reports a price of $0 for the derivative security line as presented in the filing

Insights

TL;DR: CFO acquired 58,480 stock options exercisable immediately at $1.71; routine insider compensation disclosure with a late filing noted.

The filing documents an acquisition of 58,480 stock options by Frank Richard on 04/01/2025 with an exercise price of $1.71, exercisable the same day and expiring 04/01/2035, converting into 58,480 Class A common shares. The transaction is reported as direct ownership and the Form 4 was filed late, with the filer citing an inadvertent administrative error. No earnings or other financial metrics are provided in this filing.

TL;DR: Disclosure shows a direct option grant to the CFO; tardy filing flagged as administrative error.

The document is a Form 4 reporting changes in beneficial ownership for one reporting person, Frank Richard (CFO). It records a grant/acquisition of 58,480 options (right to buy) exercisable 04/01/2025 and expiring 04/01/2035, tied to Class A common stock. The filer explicitly states the Form 4 was filed late due to an inadvertent administrative error and the form bears a signature dated 08/06/2025. This is a compliance item for record-keeping and SEC disclosure timelines.

Frank Richard, direttore finanziario di Inspire Veterinary Partners, Inc. (IVP), ha acquisito 58,480 opzioni su azioni il 04/01/2025. Le opzioni hanno un prezzo di esercizio di $1.71, sono esercitabili dal 04/01/2025 e scadono il 04/01/2035, ciascuna relativa a una azione ordinaria di Classe A. La titolarità segnalata è diretta. Il Modulo 4 indica che la presentazione è avvenuta in ritardo per un errore amministrativo involontario ed è firmato il 08/06/2025.

Frank Richard, director financiero de Inspire Veterinary Partners, Inc. (IVP), adquirió 58,480 opciones sobre acciones el 04/01/2025. Las opciones tienen un precio de ejercicio de $1.71, son ejercitables el 04/01/2025 y vencen el 04/01/2035, cada una por una acción ordinaria de Clase A. La titularidad declarada es directa. El Formulario 4 señala que la presentación se hizo con retraso debido a un error administrativo involuntario y está firmado el 08/06/2025.

Frank Richard, Inspire Veterinary Partners, Inc. (IVP)� 최고재무책임�(CFO)� 04/01/2025� 58,480주의 주식매수선택권을 취득했습니다. � 옵션� 행사가격은 $1.71이며 04/01/2025� 행사 가능하� 04/01/2035� 만료되며, � 옵션은 클래� A 보통� 1주를 대상으� 합니�. 보고� 소유 형태� 직Ϊ입니�. Form 4에는 제출� 우발적인 행정 실수� 지연되었음� 기재되어 있으� 08/06/2025� 서명되었습니�.

Frank Richard, directeur financier de Inspire Veterinary Partners, Inc. (IVP), a acquis 58,480 options d'achat d'actions le 04/01/2025. Les options ont un prix d'exercice de 1,71 $, sont exerçables le 04/01/2025 et expirent le 04/01/2035, chacune portant sur une action ordinaire de catégorie A. La propriété déclarée est directe. Le formulaire 4 indique que le dépôt a été retardé en raison d'une erreur administrative involontaire et est signé le 08/06/2025.

Frank Richard, Chief Financial Officer von Inspire Veterinary Partners, Inc. (IVP), erwarb am 04/01/2025 58,480 Aktienoptionen. Die Optionen haben einen Ausübungspreis von $1.71, sind am 04/01/2025 ausübbar und laufen am 04/01/2035 ab, wobei jede Option eine Class-A-Stammaktie abdeckt. Das gemeldete Eigentum ist direkt. Im Formular 4 wird vermerkt, dass die Einreichung aufgrund eines unbeabsichtigten administrativen Fehlers verspätet erfolgte; das Formular ist am 08/06/2025 unterschrieben.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Frank Richard

(Last) (First) (Middle)
780 LYNNHAVEN PARKWAY
SUITE 400

(Street)
VIRGINIA BEACH VA 23452

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
INSPIRE VETERINARY PARTNERS, INC. [ IVP ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Chief Financial Officer
3. Date of Earliest Transaction (Month/Day/Year)
04/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (right to buy) $1.71 04/01/2025 A 58,480 04/01/2025 04/01/2035 Class A Common Stock 58,480 $0 58,480 D
Explanation of Responses:
Remarks:
This Form 4 is being filed late due to inadvertent administrative error.
/s/ Richard Frank 08/06/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Frank Richard report for IVP?

He reported acquiring 58,480 stock options (right to buy Class A common stock) on 04/01/2025.

What are the terms of the options reported in the IVP Form 4?

The options have an exercise price of $1.71, are exercisable 04/01/2025, and expire 04/01/2035, covering 58,480 shares.

How is the ownership reported on the Form 4 for IVP?

The ownership is reported as Direct (D) and the Form indicates it was filed by one reporting person.

Was the Form 4 filed on time for IVP insider activity?

No. The Form 4 includes a remark that it was filed late due to an inadvertent administrative error; signature dated 08/06/2025.

Who is the reporting person on this IVP Form 4 and what is their role?

The reporting person is Frank Richard, who is listed as an Officer (Chief Financial Officer) of Inspire Veterinary Partners, Inc.
INSPIRE VETERINARY PARTNER

NASDAQ:IVP

IVP Rankings

IVP Latest News

IVP Latest SEC Filings

IVP Stock Data

1.89M
2.12M
0%
10.73%
13.58%
Personal Services
Consumer Cyclical
United States
VIRGINIA BEACH